GGrantIndex
← Leaderboards

Reiner Laus

Trio Pharmaceuticals Inc.

$798,212
Attributed
$798,212
Total exposure
2
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $399.5K · FY202224
$500K$375K$250K$125K$0
'22
'23
'24

Funding mix

By agency

NIH$798,212 · 2

By mechanism

R43$798,212 · 2

Top collaborators

No co-investigators on record.

Others in their field

Other Rising Stars on “Humanized Mouse

Research focus

Humanized MouseImmune SystemDesignEfficacy StudyImmuneImmune Checkpoint InhibitorClinically RelevantCohortEffector CellEfficacy EvaluationAntineoplastic AgentsAffinityAntibodiesBindingCd8b1 GeneCellsClinical TrialsCoculture TechniquesCancer CellCancer EtiologyEffector T CellCancer PatientCd34 GeneImmunity

Grant awards (2)